Jianping Zuo
12Patents
3h-index
57Co-inventors
59Inventor score
Filing activity: Jan 28, 2003 → Feb 10, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8455510B2 | Rapamycin carbonic ester analogues, pharmaceutical compositions, preparations and uses thereof | Chemistry; Metallurgy | 15 | Active |
| US7741348B2 | Bisheterocycle tandem compounds useful as antiviral agents, the uses thereof and the compositions comprising such compounds | Chemistry; Metallurgy | 10 | Expired |
| US8653115B2 | Heterocyclic non-nucleoside compounds, their preparation, pharmaceutical composition and their use as antiviral agents | Chemistry; Metallurgy | 5 | Active |
| US7626044B2 | Triptolide derivatives and their uses | Human Necessities | 3 | Expired |
| US7910750B2 | Artemisinin (qinghaosu) derivatives, their preparation methods and their use, and pharmaceutical compositions containing the same | Human Necessities | 1 | Active |
| US8247549B2 | Method for preparing 4-(6-amino-purin-9-YL)-2(S)-hydroxy-butyric acid methyl ester | Emerging Cross-Sectional Technologies | 1 | Active |
| US11045475B2 | Application of methyl 4-[9-(6-aminopuryl)]-2(s)-hydroxybutyrate in preparation of medicament for treating psoriasis and vitiligo | Human Necessities | 0 | Active |
| US8426606B2 | 2′,2-bisthiazole non-nucleoside compounds, preparation methods, pharmaceutical compositions and uses as hepatitis virus inhibitors thereof | Human Necessities | 0 | Active |
| US9133138B2 | Use of a quinazoline compound in preparing a medicament against flaviviridae virus | Emerging Cross-Sectional Technologies | 0 | Active |
| US7662860B2 | 3D-structure model of SARS coronavirus 3CL protease and anti-SARS drugs | Human Necessities | 0 | Active |
| US11040952B2 | Phthalazinone compound, method for preparation thereof, pharmaceutical composition thereof, and use thereof | Chemistry; Metallurgy | 0 | Active |
| US8129426B2 | Water-soluble artemisinin derivatives, their preparation methods, the pharmaceutical compositions and the use thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.